Ftse Mib
34.083,91
0,75%
DAX
20.232,14
0,98%
S&P 500
6.086,49
0,61%
NASDAQ
19.735,12
1,30%
Bitcoin
100.982,49
2,27%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ NeuBase Therapeutics Inc (NBSE) NeuBase Therapeutics Inc (NBSE) Notizie

NBSE

NeuBase Therapeutics (NBSE)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:NBSE
DataOraFonteTitoloSimboloCompagnia
03/07/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:NBSENeuBase Therapeutics Inc
27/06/202423:25Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:NBSENeuBase Therapeutics Inc
27/06/202423:20Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:NBSENeuBase Therapeutics Inc
27/06/202422:48Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:NBSENeuBase Therapeutics Inc
27/06/202422:46Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NBSENeuBase Therapeutics Inc
03/06/202422:08Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:NBSENeuBase Therapeutics Inc
16/05/202416:07Edgar (US Regulatory)Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securitiesNASDAQ:NBSENeuBase Therapeutics Inc
05/04/202422:05GlobeNewswire Inc.NeuBase Therapeutics Announces Receipt of Notice from NasdaqNASDAQ:NBSENeuBase Therapeutics Inc
28/12/202312:15Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:NBSENeuBase Therapeutics Inc
27/11/202315:00GlobeNewswire Inc.Psychemedics Corporation Appoints Daniella Mehalik as VP - FinanceNASDAQ:NBSENeuBase Therapeutics Inc
09/11/202322:11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NBSENeuBase Therapeutics Inc
21/09/202302:42Edgar (US Regulatory)Form 5 - Annual statement of changes in beneficial ownership of securitiesNASDAQ:NBSENeuBase Therapeutics Inc
20/09/202323:28Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:NBSENeuBase Therapeutics Inc
18/09/202322:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NBSENeuBase Therapeutics Inc
12/09/202323:20Edgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]NASDAQ:NBSENeuBase Therapeutics Inc
08/09/202313:00GlobeNewswire Inc.NeuBase Therapeutics Issues Statement Regarding Filing By ShareholderNASDAQ:NBSENeuBase Therapeutics Inc
06/09/202316:00PR Newswire (US)SYMETRYX CORPORATION ACQUIRES 20% STOCK IN NEUBASENASDAQ:NBSENeuBase Therapeutics Inc
01/09/202320:51Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:NBSENeuBase Therapeutics Inc
31/08/202317:50Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:NBSENeuBase Therapeutics Inc
11/08/202312:20Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:NBSENeuBase Therapeutics Inc
11/08/202312:15Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:NBSENeuBase Therapeutics Inc
01/08/202322:45Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:NBSENeuBase Therapeutics Inc
28/07/202312:03Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:NBSENeuBase Therapeutics Inc
07/07/202322:11Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:NBSENeuBase Therapeutics Inc
30/06/202314:43Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:NBSENeuBase Therapeutics Inc
30/06/202314:42Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:NBSENeuBase Therapeutics Inc
30/06/202314:41Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:NBSENeuBase Therapeutics Inc
05/06/202322:06Edgar (US Regulatory)Quarterly Transition Report (10-qt)NASDAQ:NBSENeuBase Therapeutics Inc
22/05/202313:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NBSENeuBase Therapeutics Inc
11/05/202322:06Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NBSENeuBase Therapeutics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:NBSE

La tua Cronologia

BIT
STLAM
Stellantis NV
BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
CPR
Davide Campari
BIT
ENI
Eni
BIT
BAMI
Banco BPM
BIT
ENEL
Enel
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
STMMI
ST Microelectronics
BIT
SPM
Saipem
BIT
BPE
Bper Banca
BIT
RACE
Ferrari NV
BIT
TEN
Tenaris
BIT
MONC
Moncler
BIT
PRY
Prysmian
BIT
LDO
Leonardo
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network